Efficacy and safety of first-line therapies in EGFR-mutated advanced non-small-cell lung cancer: a network meta-analysis-论文-万方医学网

首页> > Efficacy and safety of first-line therapies in EGFR-mutated advanced non-small-cell lung cancer: a network meta-analysis

Efficacy and safety of first-line therapies in EGFR-mutated advanced non-small-cell lung cancer: a network meta-analysis

导出原文传递

翻译打印收藏纠错

第一作者： Haeussler, Katrin

作者： Haeussler, Katrin ^[1] ; Wang, Xuan ^[2] ; Winfree, Katherine B. ^[3] ; D'yachkova, Yulia ^[4] ; Traore, Sory ^[5] ; Puri, Tarun ^[6] ; Thom, Howard ; Papagiannopoulos, Christos ; Nassim, Maria ; Taipale, Kaisa

作者单位： ICON Plc ^[1] Eli Lilly & Co ^[2] Eli Lilly GmbH ^[3] Eli Lilly & Co India Pvt Ltd ^[4] Bristol Med Sch Populat Hlth Sci,Univ Bristol ^[5] Oy Eli Lilly Finland Ab ^[6]

关键词 EGFR positive network meta-analysis non-small-cell lung cancer progression-free survival systematic literature review tyrosine kinase inhibitors LONG-TERM RESPONDERS RANDOMIZED PHASE-II PLUS NSCLC ANALYSIS QUALITY-OF-LIFE GEFITINIB MAINTENANCE THERAPY PATIENT-REPORTED OUTCOMES RECEPTOR GENE-MUTATIONS OPEN-LABEL ASIAN PATIENTS SYSTEMATIC REVIEWS

发布时间 2022-08-26

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

相似文献

中文期刊
外文期刊
学位论文
会议论文

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

法律状态公告日	法律状态	法律状态信息

检索历史清除

Efficacy and safety of first-line therapies in EGFR-mutated advanced non-small-cell lung cancer: a network meta-analysis

相似文献

同项目论文

相关期刊

检索历史 清除

Efficacy and safety of first-line therapies in EGFR-mutated advanced non-small-cell lung cancer: a network meta-analysis

相似文献

同项目论文

相关期刊

检索历史清除